Judgment Entered For Novo Nordisk In FCA Dispute Over Hemophilia Drug
TACOMA, Wash. — A Washington federal court jury found in favor of Novo Nordisk Inc. (NNI) in a qui tam suit accusing it of violating the federal False Claims Act (FCA)...To view the full article, register now.
Already a subscriber? Click here to view full article